PHASEBIO PHARMACEUTICALS, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
0.00% | 0.00% |
Chart calendar PhaseBio Pharmaceuticals, Inc.
c8d081578bfec4f1677d287a.N8ZLd7bIiS4mcLw_5LuPZAgiHXl09flqkCKs-DbhaQw.Wag5RuKa4F9CMtFSncv3FDp0LRcsxbU5pBHjj3OnWWR9sSw-7JLwW1Ui8Q~d49f5615dadea4f4fcec877f7e2c8ed3
Upcoming events on PhaseBio Pharmaceuticals, Inc.
No events available
Past events on PhaseBio Pharmaceuticals, Inc.
| 12/08/2022 13:30 | Interim 2022 Earnings Release |
| 19/05/2022 16:00 | Annual General Meeting |
| 16/05/2022 13:30 | Business Update Call |
| 16/05/2022 11:00 | Q1 2022 Earnings Release |
| 14/04/2022 18:30 | Needham Virtual Healthcare Conference |
| 02/04/2022 17:15 | American College of Cardiology Scientific Conference - 403-10 |
| 24/03/2022 20:00 | FY 2021 Earnings Release |
| 08/03/2022 17:50 | Cowen & Co. Health Care Conference - Panel |
| 15/11/2021 17:30 | REVERSE-IT Phase 3 Trial Results Call |
| 10/11/2021 21:00 | Q3 2021 Earnings Release |
| 13/09/2021 12:00 | H.C. Wainwright Global Investment Conference |
| 12/08/2021 13:30 | Interim 2021 Earnings Release |
| 15/07/2021 18:00 | William Blair Biotech Focus Conference |
| 17/06/2021 13:30 | Business Update Call |
| 02/06/2021 | Annual General Meeting |
| 13/05/2021 21:00 | Q1 2021 Earnings Release |
| 15/04/2021 16:00 | Needham Healthcare Conference |
| 15/03/2021 16:00 | Analyst Day |
| 15/03/2021 16:00 | Investor and Analyst Day |
| 15/03/2021 12:00 | FY 2020 Earnings Release |
Annual results
| Fiscal Period | December | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,67 0,41 63.99% | 2,36 1,80 31.47% | 0,32 0,30 8.11% | 10,8 10,5 3.01% |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -19,6 -21,1 6.78% | -39,7 -40,3 1.49% | -84,9 -79,6 -6.64% | -107 -106 -1.29% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -23,8 -24,2 1.46% | -39,2 -40,8 3.82% | -98,6 -87,1 -13.23% | -129 -111 -17.16% |
|
Net income Million USD | Released Forecast Spread | -10,2 | -23,8 -28,9 17.53% | -39,2 -39,6 0.77% | -98,6 -88,0 -11.95% | -131 -118 -10.86% |
|
EPS USD | Released Forecast Spread | -13,8 | -2,24 -2,39 6.08% | -1,43 -1,43 0.28% | -3,39 -3,02 -12.1% | -2,98 -2,68 -11.28% |
| Announcement Date | 21/09/18 | 26/03/19 | 30/03/20 | 15/03/21 | 24/03/22 |
Quarterly results
| Fiscal Period | December | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,13 - | 0,00 0,14 - | 0,00 0,05 - | 0,00 0,02 - | 10,3 5,02 105.94% | 0,34 1,07 -68.58% | 0,16 1,97 -91.96% | 0,12 2,33 -94.99% | 0,21 0,50 -58.4% |
|
EBITDA Million USD | Released Forecast Spread | -18,2 -26,9 32.25% | -25,3 -20,6 -22.7% | |||||||
|
EBIT Million USD | Released Forecast Spread | -24,1 -14,7 -64.28% | -20,5 -21,8 5.96% | -26,0 -20,7 -25.7% | -25,6 -23,2 -10.55% | -21,1 -19,3 -9.31% | -28,6 -27,8 -2.8% | -32,1 -28,6 -12.24% | -18,2 -29,8 38.9% | -25,3 -19,1 -32.33% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -28,1 -14,9 -89% | -25,1 -21,0 -19.46% | -30,4 -18,9 -60.54% | -27,4 -23,5 -16.46% | -27,1 -24,6 -9.86% | -31,9 -30,5 -4.53% | -43,1 -30,2 -42.51% | -11,1 -32,1 65.34% | -16,7 -20,6 19.21% |
|
Net income Million USD | Released Forecast Spread | -28,1 -14,7 -91.04% | -25,1 -22,0 -14.51% | -30,4 -19,9 -52.7% | -27,4 -23,5 -16.65% | -28,7 -19,6 -46.59% | -31,9 -29,1 -9.64% | -43,1 -30,2 -42.77% | -11,1 -32,1 65.34% | -16,7 -20,6 19.21% |
|
EPS USD | Released Forecast Spread | -0,98 -0,51 -92.16% | -0,86 -0,71 -21.47% | -1,03 -0,67 -53.73% | -0,87 -0,73 -18.53% | -0,60 -0,46 -30.43% | -0,66 -0,61 -8.91% | -0,85 -0,58 -47.19% | -0,23 -0,66 65.36% | -0,34 -0,31 -8.8% |
| Announcement Date | 11/08/20 | 12/11/20 | 15/03/21 | 13/05/21 | 12/08/21 | 10/11/21 | 24/03/22 | 16/05/22 | 12/08/22 |
More events
Past sector events for PhaseBio Pharmaceuticals, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PHAS.Q Stock
- Calendar PhaseBio Pharmaceuticals, Inc.
